Holen Sie sich die Stockscreener-App
8.12
5.69%
-0.49
Handel nachbörslich:
7.97
-0.15
-1.85%
Schlusskurs vom Vortag:
$8.61
Offen:
$8.7
24-Stunden-Volumen:
1.27M
Relative Volume:
1.30
Marktkapitalisierung:
$720.06M
Einnahmen:
$73.48M
Nettoeinkommen (Verlust:
$-108.30M
KGV:
-3.6089
EPS:
-2.25
Netto-Cashflow:
$-67.17M
1W Leistung:
+10.63%
1M Leistung:
+50.65%
6M Leistung:
+167.99%
1J Leistung:
+64.37%
1-Tages-Spanne:
$8.05
$8.84
1-Wochen-Bereich:
$7.17
$8.85
52-Wochen-Spanne:
$2.8262
$8.85
Personalis Inc Stock (PSNL) Company Profile
Firmenname
Personalis Inc
Sektor
Branche
Telefon
650-752-1300
Adresse
6600 DUMBARTON CIRCLE, FREMONT, CA
Vergleichen Sie PSNL mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
PSNL
Personalis Inc
|
8.12 | 763.51M | 73.48M | -108.30M | -67.17M | -2.25 |
|
TMO
Thermo Fisher Scientific Inc
|
524.80 | 201.90B | 43.21B | 6.58B | 6.17B | 17.28 |
|
DHR
Danaher Corp
|
202.46 | 146.42B | 24.01B | 3.41B | 4.86B | 4.7082 |
|
IDXX
Idexx Laboratories Inc
|
616.15 | 50.30B | 4.04B | 985.66M | 774.34M | 12.01 |
|
A
Agilent Technologies Inc
|
136.62 | 39.72B | 6.79B | 1.22B | 1.09B | 4.2644 |
|
IQV
Iqvia Holdings Inc
|
198.17 | 34.51B | 15.70B | 1.24B | 2.01B | 6.9036 |
Personalis Inc Stock (PSNL) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-05-15 | Eingeleitet | Guggenheim | Buy |
| 2025-03-17 | Eingeleitet | Craig Hallum | Buy |
| 2023-02-06 | Hochstufung | Needham | Hold → Buy |
| 2022-01-07 | Hochstufung | BofA Securities | Neutral → Buy |
| 2021-11-05 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2021-11-03 | Herabstufung | Needham | Buy → Hold |
| 2021-10-15 | Fortgesetzt | Cowen | Outperform |
| 2021-09-20 | Bestätigt | Needham | Buy |
| 2021-05-06 | Hochstufung | Oppenheimer | Perform → Outperform |
| 2021-01-28 | Eingeleitet | Truist | Buy |
| 2021-01-04 | Herabstufung | BofA Securities | Buy → Neutral |
| 2020-11-12 | Bestätigt | Needham | Buy |
| 2020-11-06 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2020-10-19 | Eingeleitet | Citigroup | Buy |
| 2020-10-08 | Eingeleitet | BTIG Research | Buy |
| 2020-08-27 | Eingeleitet | H.C. Wainwright | Buy |
| 2020-08-18 | Eingeleitet | Needham | Buy |
| 2019-09-26 | Hochstufung | BofA/Merrill | Neutral → Buy |
| 2019-07-15 | Eingeleitet | BofA/Merrill | Neutral |
| 2019-07-15 | Eingeleitet | Cowen | Outperform |
| 2019-07-15 | Eingeleitet | Morgan Stanley | Overweight |
| 2019-07-15 | Eingeleitet | Oppenheimer | Outperform |
Alle ansehen
Personalis Inc Aktie (PSNL) Neueste Nachrichten
Analyzing net buyer seller activity in Personalis Inc.Weekly Stock Summary & Long-Term Growth Stock Strategies - newser.com
How to monitor Personalis Inc. with trend dashboardsWeekly Market Outlook & Precise Buy Zone Tips - newser.com
Visual trend scoring systems applied to Personalis Inc.2025 Support & Resistance & Low Risk High Reward Trade Ideas - newser.com
Forecasting Personalis Inc. price range with options dataEarnings Growth Report & Safe Capital Growth Plans - newser.com
Price momentum metrics for Personalis Inc. explained2025 Trading Volume Trends & Fast Gain Stock Trading Tips - newser.com
Personalis, Inc. Hits New 52-Week High of $8.70, Up 557.58% - Markets Mojo
Understanding Personalis Inc.’s price movementPortfolio Return Report & Community Trade Idea Sharing - newser.com
What MACD signals say about Personalis Inc.Quarterly Trade Report & Weekly Momentum Picks - newser.com
Analyzing Personalis Inc. with risk reward ratio chartsDividend Hike & AI Optimized Trading Strategy Guides - newser.com
Personalis (NASDAQ:PSNL) Reaches New 1-Year HighHere's What Happened - MarketBeat
Head-To-Head Review: Parnell Pharmaceuticals (OTCMKTS:PARNF) versus Personalis (NASDAQ:PSNL) - Defense World
Personalis (NASDAQ:PSNL) surges 13% this week, taking three-year gains to 153% - simplywall.st
What analysts say about Personalis Inc 04X stockMarket Timing Techniques & Free Get High Impact Recommendations - earlytimes.in
Exit strategy if you’re trapped in Personalis Inc.Market Movement Recap & Daily Profit Focused Stock Screening - newser.com
Why Personalis Inc. stock could be next big winner2025 Investor Takeaways & AI Driven Price Forecasts - newser.com
What indicators show strength in Personalis Inc.Market Performance Recap & Advanced Technical Signal Analysis - newser.com
Will Personalis Inc. stock outperform tech sector in 2025Market Activity Report & Stepwise Entry and Exit Trade Signals - newser.com
Personalis (NASDAQ:PSNL) Trading 8.9% HigherStill a Buy? - MarketBeat
Volume spikes in Personalis Inc. stock – what they meanJuly 2025 Action & Free Long-Term Investment Growth Plans - newser.com
What drives Personalis Inc stock priceSwing Trading Watchlist & Identify Winning Stocks - earlytimes.in
Goldman Sachs Group Inc. Has $998,000 Stock Position in Personalis, Inc. $PSNL - MarketBeat
Personalis (NASDAQ:PSNL) Upgraded at Wall Street Zen - MarketBeat
Personalis (NASDAQ:PSNL) Trading 7.5% HigherHere's Why - MarketBeat
Acadian Asset Management LLC Reduces Position in Personalis, Inc. $PSNL - MarketBeat
Personalis, Inc. (NASDAQ:PSNL) Receives $7.42 Consensus Price Target from Analysts - MarketBeat
Retail Trends: Is RPTX benefiting from interest rate changesOptions Play & Safe Capital Growth Plans - khodrobank.com
Should you hold or exit Personalis Inc. nowPortfolio Profit Report & Real-Time Buy Zone Alerts - newser.com
Aug Gainers: Will Freedom Holding Corp outperform small cap indexesRisk Management & Low Risk Growth Stock Ideas - khodrobank.com
What earnings revisions data tells us about Personalis Inc.2025 Key Lessons & High Accuracy Investment Signals - newser.com
Finanzdaten der Personalis Inc-Aktie (PSNL)
Umsatz
Nettogewinn
Free Cashflow
ENV
Personalis Inc-Aktie (PSNL) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Tachibana Aaron | CFO AND COO |
Jul 28 '25 |
Sale |
6.57 |
641 |
4,211 |
164,458 |
| Tachibana Aaron | CFO AND COO |
May 16 '25 |
Sale |
4.95 |
1,291 |
6,390 |
165,099 |
| Moore Stephen Michael | SVP and Chief Legal Officer |
May 16 '25 |
Sale |
4.95 |
1,675 |
8,291 |
64,200 |
| Chen Richard | CHIEF MEDICAL OFFICER AND EVP |
May 16 '25 |
Sale |
4.95 |
910 |
4,504 |
124,957 |
| Tachibana Aaron | CFO AND COO |
Jan 28 '25 |
Sale |
5.79 |
708 |
4,099 |
166,390 |
| Chen Richard | CHIEF MEDICAL OFFICER AND EVP |
Jan 28 '25 |
Sale |
5.79 |
519 |
3,005 |
123,367 |
| Chen Richard | CHIEF MEDICAL OFFICER AND EVP |
Dec 16 '24 |
Sale |
3.82 |
4,834 |
18,466 |
123,886 |
| Moore Stephen Michael | SVP and Chief Legal Officer |
Dec 16 '24 |
Sale |
3.82 |
1,513 |
5,780 |
65,875 |
| Tachibana Aaron | CFO AND COO |
Dec 16 '24 |
Sale |
3.82 |
6,865 |
26,224 |
167,098 |
| Tachibana Aaron | CFO AND COO |
Nov 18 '24 |
Sale |
3.79 |
1,307 |
4,954 |
173,963 |
0.17%
2.19%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):